Medtech & Pharma Platform Association

Tweet this page
Registration as it was on 05 Oct 2022
How to read and use this data card.
Download this datacard


Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

0.75 Fte (2)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Medtech & Pharma Platform Association   (MPP)

    EU Transparency Register

    234427831877-10 First registered on 25 Jun 2018

    Goals / Remit

    The Medtech & Pharma Platform Association (MPP) is a European cross-sectoral not-for-profit industry Association focusing on combined products, i.e. products that combine drugs, devices, diagnostics and/or digital elements to fulfill a medical purpose. Members are medtech, pharma and tech companies as well as organizations dedicated to enhancing synergies between the sectors. Current and future innovative healthcare solutions increasingly rely on combined products, integrating various combinations of pharma, medtech and digital technologies. MPP offers expertise and seeks dialogue with relevant stakeholders to collaborate on a proportionate regulatory framework for combined products, with a view to facilitate patient access to innovation, foster European competitiveness and enhance the safety of health data.

    Main EU files targeted

    The Medtech & Pharma Platform Association was founded in 2017 and started its activities in 2018.

    The Medtech & Pharma Platform monitors EU legislative, policy and regulatory developments relating to combined products.

    Specifically, the Medtech & Pharma Platform follows:
    • Medical Devices Regulation EU 2017/745 & In vitro Diagnostics Regulation EU 2017/746
    and their implementing and delegated acts as well as any related guidance document
    • Medicinal Products Directive EU 2001/83
    • Advanced Therapy Medicinal Product Regulation EU 1394/2007
    • Regulation on Health Technology Assessment EU 2021/2282
    • General Data Protection Regulation EU 2016/679
    • Clinical Trials Regulation EU 536/2014
    • Proposals for Data Governance Act and Data Act
    • Proposal for Regulation on Artificial Intelligence
    • Policy initiatives, projects, events and publications from DG SANTE, DG GROW, DG CONNECT, DG RESEARCH & INNOVATION
    • European Health and Digital Executive Agency (HaDEA)
    • Health emergency preparedness and response authority (HERA)
    • EU Pharmaceutical Strategy
    • Revision of the EU basic pharmaceutical legislation
    • New Industrial strategy for Europe
    • European Digital Strategy and Artificial Intelligence
    • Horizon Europe
    • European Health Data Space
    • EU Beating Cancer Plan
    • European Health Union
    • Intellectual property action plan
    • Institutional agreement Switzerland-EU


    Head Office
    Medtech & Pharma Platform Association c/o SFL Regulatory Affairs & Scientific Communication GmbH Aeschenvorstadt 52
    Basel 4051
    EU Office
    Medtech & Pharma Platform Association c/o SFL Regulatory Affairs & Scientific Communication GmbH Aeschenvorstadt 52
    Basel 4051


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Within the cluster of 25% working time, two people work 12.5% making a joint total of 25%. In total, 3 people are involved.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Trade and business associations

  • Networking



    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    MPP is funded by membership contributions.

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Other activities

    MPP is acknowledged as Industry stakeholder for interaction with the European Medicines Agency (EMA)

  • Meetings


    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

Download this datacard